在ALL-BFM 2000试验中接受治疗的急性淋巴细胞白血病儿童对天然L-天冬酰胺酶的超敏反应：诱导治疗方案和糖皮质激素类型的影响 - Suppr

Hypersensitivity Reactions to Native L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction.

作者信息

Möricke Anja, Rizzari Carmelo, Alten Julia, Attarbaschi Andishe, Beier Rita, Biondi Andrea, Burkhardt Birgit, Bodmer Nicole, Boos Joachim, Cario Gunnar, Conter Valentino, Flotho Christian, Kulozik Andreas, Lanvers-Kaminsky Claudia, Mann Georg, Niggli Felix, Silvestri Daniela, von Stackelberg Arend, Stanulla Martin, Valsecchi Maria-Grazia, Schrappe Martin, Zimmermann Martin

机构信息

Department of Pediatrics I, Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.

Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.

出版信息

Hemasphere. 2023 Jun 1;7(6):e888. doi: 10.1097/HS9.0000000000000888. eCollection 2023 Jun.

DOI:10.1097/HS9.0000000000000888

PMID:37275738

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10238044/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e8/10238044/ddedcfcbc00b/hs9-7-e888-g001.jpg

相似文献

Hypersensitivity Reactions to Native L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction.

Hemasphere. 2023 Jun 1;7(6):e888. doi: 10.1097/HS9.0000000000000888. eCollection 2023 Jun.

Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.

Lancet Haematol. 2023 Jun;10(6):e419-e432. doi: 10.1016/S2352-3026(23)00072-8. Epub 2023 May 8.

Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols.

Br J Haematol. 2000 Aug;110(2):379-84. doi: 10.1046/j.1365-2141.2000.02187.x.

Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia.

Leukemia. 1998 May;12(5):660-5. doi: 10.1038/sj.leu.2401007.

Optimizing asparaginase therapy for acute lymphoblastic leukemia.

Curr Opin Oncol. 2013 Mar;25 Suppl 1:S1-9. doi: 10.1097/CCO.0b013e32835d7d85.

Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment.

Br J Haematol. 2001 Sep;114(4):794-9. doi: 10.1046/j.1365-2141.2001.03009.x.

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.

Lancet Oncol. 2015 Dec;16(16):1677-90. doi: 10.1016/S1470-2045(15)00363-0. Epub 2015 Nov 6.

[New possibilities of treatment with PEG-L-asparaginase in patients with acute lymphoblastic leukemia sensitized to l-asparaginase E.coli and erwinase].

Wiad Lek. 1998;51 Suppl 4:233-6.

Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia.

J Allergy Clin Immunol. 2009 Apr;123(4):895-9. doi: 10.1016/j.jaci.2008.10.034. Epub 2008 Dec 10.

Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

J Pediatr Hematol Oncol. 2011 Dec;33(8):610-6. doi: 10.1097/MPH.0b013e31822d4d4e.

引用本文的文献

Recent advances in L-Asparaginase enzyme production and formulation development for acrylamide reduction during food processing.

Food Chem X. 2024 Dec 2;25:102055. doi: 10.1016/j.fochx.2024.102055. eCollection 2025 Jan.

Back to the future: the amazing journey of the therapeutic anti-leukemia enzyme asparaginase .

Haematologica. 2023 Oct 1;108(10):2606-2615. doi: 10.3324/haematol.2022.282324.

Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol.

Hemasphere. 2023 Jun 1;7(6):e893. doi: 10.1097/HS9.0000000000000893. eCollection 2023 Jun.

本文引用的文献

Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol.

Hemasphere. 2023 Jun 1;7(6):e893. doi: 10.1097/HS9.0000000000000893. eCollection 2023 Jun.

Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group.

Eur J Cancer. 2022 Feb;162:65-75. doi: 10.1016/j.ejca.2021.11.016. Epub 2021 Dec 23.

Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia.

Blood. 2021 Apr 29;137(17):2373-2382. doi: 10.1182/blood.2020006583.

Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

J Clin Oncol. 2020 Jun 10;38(17):1897-1905. doi: 10.1200/JCO.19.03024. Epub 2020 Apr 10.

Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia.

Hematol Transfus Cell Ther. 2021 Jan-Mar;43(1):9-14. doi: 10.1016/j.htct.2019.10.007. Epub 2020 Jan 22.

Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.

Leukemia. 2020 Jun;34(6):1694-1700. doi: 10.1038/s41375-019-0670-y. Epub 2019 Dec 5.

Context-Dependent Effect of Glucocorticoids on the Proliferation, Differentiation, and Apoptosis of Regulatory T Cells: A Review of the Empirical Evidence and Clinical Applications.

Int J Mol Sci. 2019 Mar 6;20(5):1142. doi: 10.3390/ijms20051142.

Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).

J Clin Oncol. 2018 Jan 20;36(3):244-253. doi: 10.1200/JCO.2017.74.4946. Epub 2017 Nov 17.

Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL.

Blood. 2017 Nov 9;130(19):2146-2149. doi: 10.1182/blood-2017-05-782086. Epub 2017 Sep 22.

Allergic-like reactions to asparaginase: Atypical allergies without asparaginase inactivation.

Pediatr Blood Cancer. 2016 Nov;63(11):1928-34. doi: 10.1002/pbc.26123. Epub 2016 Jul 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Hypersensitivity Reactions to Native L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献